Department of Internal Medicine III, Jena University Hospital, Jena, Germany.
Diabet Med. 2013 Mar;30(3):e91-4. doi: 10.1111/dme.12071.
To investigate the supposition that self-adjustment of insulin dose will improve metabolic control in patients with Type 2 diabetes.
The number of self-adjustments of insulin dose was checked in a cross-sectional study involving 300 patients with Type 2 diabetes in a university outpatient department, who were insulin treated.
One hundred and ninety-three patients (64%) performed insulin dose adjustments at least once in 14 days. The mean number of dose adjustments was 17.4 per 14 days. Patients with self-adjustments of insulin dose were younger (65.6 vs. 68.9 years), had a higher social status score (11.1 vs. 9.8) and a higher insulin dose (68.8 vs. 53.6 IU/day) than patients without dose adjustments. Each insulin dose adjustment was associated with an HbA(1c) decrease of 0.016% (P = 0.004). Any additional blood glucose self measurement was associated with an HbA(1c) increase of 0.019% (P = 0.038).
Two-thirds of patients with Type 2 diabetes, who have undergone training in how to manage their condition, practise insulin dose self-adjustments. A weak association was observed between insulin dose adjustments and HbA(1c).
调查关于自行调整胰岛素剂量可以改善 2 型糖尿病患者代谢控制的假设。
通过横断面研究,检查了 300 名在大学门诊接受胰岛素治疗的 2 型糖尿病患者的胰岛素剂量自行调整次数。
193 名(64%)患者在 14 天内至少进行了一次胰岛素剂量调整。平均每 14 天调整 17.4 次剂量。与未调整剂量的患者相比,进行胰岛素剂量调整的患者年龄更小(65.6 岁 vs. 68.9 岁),社会地位评分更高(11.1 分 vs. 9.8 分),胰岛素剂量更高(68.8IU/天 vs. 53.6IU/天)。每次胰岛素剂量调整与 HbA1c 降低 0.016%相关(P=0.004)。任何额外的血糖自我监测与 HbA1c 升高 0.019%相关(P=0.038)。
在接受如何管理病情培训的 2 型糖尿病患者中,有三分之二的患者会自行调整胰岛素剂量。观察到胰岛素剂量调整与 HbA1c 之间存在微弱关联。